Chapter 11: Structure-based design technology Contour and its application to drug discovery

RSC Biomolecular Sciences

Volumn , Issue , 2012, Pages 265-280

  Liu, Zhijie ^a   Lindblom, Peter ^a   Claremon, David A ^a   Singh, Suresh B ^a  

^a Vitae Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; OXIDOREDUCTASE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; DRUG DEVELOPMENT; ENZYME ACTIVE SITE; FRAGMENTATION REACTION; MEDICAL TECHNOLOGY; MOLECULAR WEIGHT; PROTEIN DATA BANK; SUPPORT VECTOR MACHINE; THEORY; X RAY; ALGORITHM; BINDING AFFINITY; BINDING SITE; COMPUTER AIDED DESIGN; COMPUTER INTERFACE; HYDROGEN BOND; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 84872564827     PISSN: 17577152     EISSN: 17577160     Source Type: Book Series    
DOI: None     Document Type: Article

References (48)

1. J. Drews, Science, 2000, 287, 1960-1964.
2. L. J. Gershell and J. H. Atkins, Nat Rev Drug Discov, 2003, 2, 321-327.
3. A. L. Harren Jhoti, ed., Structure-based Drug Discovery, 1st Edition edn, Springer, 2007.
4. J. W. H. M. Berman, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov and P. E. Bourne, Nucleic Acids Research, 2000, 28, 235-242.
5. H. J. Böhm, Prediction of Non-bonded Interactions in Drug Design, Wiley- VCH Verlag GmbH & Co. KGaA, 2005.
6. M. A. Williams and J. E. Ladbury, Hydrogen Bonds in Protein-Ligand Complexes, Wiley-VCH Verlag GmbH & Co. KGaA, 2005.
7. D. B. Kitchen, H. Decornez, J. R. Furr and J. Bajorath, Nat Rev Drug Discov, 2004, 3, 935-949.
8. R. D. Cramer, D. E. Patterson and J. D. Bunce, Journal of the American Chemical Society, 1988, 110, 5959-5967.
9. W. P. Jencks, Proceedings of the National Academy of Sciences, 1981, 78, 4046-4050.
10. C. Mattos and D. Ringe, Nat Biotech, 1996, 14, 595-599.
11. P. J. Hajduk and J. Greer, Nat Rev Drug Discov, 2007, 6, 211-219.
12. P. J. Hajduk, W. R. J. D. Galloway and D. R. Spring, Nature, 470, 42-43.
13. P. J. Hajduk, R. P. Meadows and S. W. Fesik, Science, 1997, 278, 497-499.
14. D. A. Erlanson, J. A. Wells and A. C. Braisted, Annu Rev Biophys Biomol Struct, 2004, 33, 199-223.
15. C. W. Murray and T. L. Blundell, Current Opinion in Structural Biology, 2010, 20, 497-507.
16. F. Vajda S. Fau - Guarnieri and F. Guarnieri, Curr. Opin. Drug Discov. Devel., 2006.
17. D. J. Danziger and P. M. Dean, Proceedings of the Royal Society of London. Series B, Biological Sciences, 1989, 236, 115-124.
18. J. B. Moon and W. J. Howe, Proteins: Structure, Function, and Bioinformatics, 1991, 11, 314-328.
19. K. Appelt, R. J. Bacquet, C. A. Bartlett, C. L. J. Booth, S. T. Freer, M. A. M. Fuhry, M. R. Gehring, S. M. Herrmann and E. F. Howland, Journal of Medicinal Chemistry, 1991, 34, 1925-1934.
20. R. S. Bohacek and C. McMartin, Journal of the American Chemical Society, 1994, 116, 5560-5571.
21. S. H. Rotstein and M. A. Murcko, Journal of Computer-Aided Molecular Design, 1993, 7, 23-43.
22. V. J. Gillet, W. Newell, P. Mata, G. Myatt, S. Sike, Z. Zsoldos and A. P. Johnson, Journal of Chemical Information and Computer Sciences, 1994, 34, 207-217.
23. C. McMartin and R. S. Bohacek, Journal of Computer-Aided Molecular Design, 1997, 11, 333-344.
24. A. S. Ripka, R. S. Bohacek and D. H. Rich, Bioorganic & Medicinal Chemistry Letters, 1998, 8, 357-360.
25. R. Wang, Y. Gao and L. Lai, Journal of Molecular Modeling, 2000, 6, 498-516.
26. B. A. Grzybowski, A. V. Ishchenko, J. Shimada and E. I. Shakhnovich, Accounts of Chemical Research, 2002, 35, 261-269.
27. J. Shimada, The Challenges of Making Useful Protein-Ligand Free Energy Predictions for Drug Discovery, John Wiley & Sons, Inc., 2006.
28. W. L. Jorgensen, J. Ruiz-Caro, J. Tirado-Rives, A. Basavapathruni, K. S. Anderson and A. D. Hamilton, Bioorganic & Medicinal Chemistry Letters, 2006, 16, 663-667.
29. P. S. Kutchukian and E. I. Shakhnovich, Expert Opinion on Drug Discovery, 2010, 5, 789-812.
30. J. Bajorath, M. Hartenfeller and G. Schneider, in Chemoinformatics and Computational Chemical Biology, Humana Press, Editon edn, 2011, vol. 672, pp. 299-323.
31. (a) B. R. Brooks, R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan and M. Karplus, Journal of Computational Chemistry, 1983, 4, 187-217;;
32. (b) A. D. MacKerell, Jr., D. Bashford, M. Bellott, R. L. Dunbrack, Jr., J. D. Evanseck, M. J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy, L. Kuchnir, K. Kuczera, F. T. K. Lau, C. Mattos, S. Michnick, T. Ngo, D. T. Nguyen, B. Prodhom, W. E. Reiher, III, B. Roux, M. Schlenkrich, J. C. Smith, R. Stote, J. Straub, M. Watanabe, J. Wió rkiewicz-Kuczera, D. Yin and M. Karplus, Journal of Physical Chemistry B, 1998, 102, 3586-3616.
33. J. J. Irwin and B. K. Shoichet, Journal of Chemical Information and Modeling, 2004, 45, 177-182.
34. F. Allen, Acta Crystallographica Section B, 2002, 58, 380-388.
35. M. Wamil and J. R. Seckl, Drug Discovery Today, 2007, 12, 504-520.
36. M. S. Cooper and P. M. Stewart, Journal of Clinical Endocrinology Metabolism, 2009, 94, 4645-4654.
37. C. M. T. Suresh and B. Singh, Current Pharmaceutical Biotechnology, 2010, 11, 779-791.
38. B. Sahni-Arya, M. J. Flynn, L. Bergeron, M. E. K. Salyan, D. L. Pedicord, R. Golla, Z. Ma, H. Wang, R. Seethala, S. C. Wu, J. J. Li, A. Nayeem, C. Gates, L. G. Hamann, D. A. Gordon and Y. Blat, Biochim. Biophys. Acta, Proteins Proteomics, 2007, 1774, 1184-1191.
39. H. Tu, J. P. Powers, J. Liu, S. Ursu, A. Sudom, X. Yan, H. Xu, D. Meininger, M. DeGraffenreid, X. He, J. C. Jaen, D. Sun, M. Labelle, H. Yamamoto, B. Shan, N. P. C. Walker and Z. Wang, Bioorg. Med. Chem., 2008, 16, 8922-8931.
40. R. C. Andrews, O. Rooyackers and B. R. Walker, J. Clin. Endocrinol. Metab., 2003, 88, 285-291.
41. T. C. Sandeep, R. Andrew, N. Z. M. Homer, R. C. Andrews, K. Smith and B. R. Walker, Diabetes, 2005, 54, 872-879.
42. T. Barf, J. Vallgå rda, R. Emond, C. Haeggstroem, G. Kurz, A. Nygren, V. Larwood, E. Mosialou, K. Axelsson, R. Olsson, L. Engblom, N. Edling, Y. Roenquist-Nii, B. Oehman, P. Alberts and L. Abrahmsen, J. Med. Chem., 2002, 45, 3813-3815.
43. D. J. St. Jean, Jr., M. Wang and C. Fotsch, Curr. Top. Med. Chem. (Sharjah, United Arab Emirates), 2008, 8, 1508-1523.
44. C. D. Boyle, Curr. Opin. Drug Discovery Dev., 2008, 11, 495-511.
45. C. G. Schnackenberg, Curr. Opin. Invest. Drugs (Thomson Sci.), 2008, 9, 295-300.
46. C. M. Tice, W. Zhao, Z. Xu, S. T. Cacatian, R. D. Simpson, Y.-J. Ye, S. B. Singh, B. M. McKeever, P. Lindblom, J. Guo, P. M. Krosky, B. A. Kruk, J. Berbaum, R. K. Harrison, J. J. Johnson, Y. Bukhtiyarov, R. Panemangalore, B. B. Scott, Y. Zhao, J. G. Bruno, L. Zhuang, G. M. McGeehan, W. He and D. A. Claremon, Bioorganic &Medicinal Chemistry Letters, 20, 881-886.
47. C. M. Tice, W. Zhao, P. M. Krosky, B. A. Kruk, J. Berbaum, J. A. Johnson, Y. Bukhtiyarov, R. Panemangalore, B. B. Scott, Y. Zhao, J. G. Bruno, L. Howard, J. Togias, Y.-J. Ye, S. B. Singh, B. M. McKeever, P. R. Lindblom, J. Guo, R. Guo, H. Nar, A. Schuler-Metz, R. E. Gregg, K. Leftheris, R. K. Harrison, G. M. McGeehan, L. Zhuang and D. A. Claremon, Bioorganic & Medicinal Chemistry Letters, 20, 6725-6729.
48. Chembridge Corporation. Screening Collection. Hit2Lead.com, 2010.